DCBG-like Pol IIIC inhibitors (Acurx Pharmaceuticals/Wuxi)

N/A

Report date: 2025/01/26 16:54:32
NME

Base Information

Drug NameDCBG-like Pol IIIC inhibitors (Acurx Pharmaceuticals/Wuxi)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolC protein, bacteria inhibitors
TargetsPolC protein, bacteria
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAcurx Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Apptec Co LtdAcurx Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsGram-Positive Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A